Imported item 88

Posted:
7
March 2011

Richmond Pharmacology welcomes you to attend this year�s Joint Conference of Human Pharmacology Societies and 20th Anniversary of AGAH, taking place in Berlin, Germany from 31 March to April 1st.

The German AGAH e.V., the French Club Phase I, the Belgian BAPU and the British AHPPI have joined forces organising this conference, with particular focus placed on the �Exploratory Development of Modern Therapies � Biologicals, Advanced Therapies and Drug-Device Combinations�.

There will be an interesting programme offered, with an expert panel of pan-European speakers, providing ample opportunity to discuss ideas, strategies, methods, technologies and experience with the early development of modern therapies in two days of plenary sessions and workshops. The conference will provide an ideal platform for human pharmacologists working in pharmaceutical companies, CROs and academic units in Europe to come together and share knowledge and ideas.

During the conference, Dr Jorg Taubel will chair a workshop on  QT-Studies for biologicals   and Dr Ulrike Lorch will give an introduction to a forum discussion on the  Need for a uniform European accreditation system for Phase 1 units .

For a full outline of each day�s activities please click here

To register for the meeting please complete the online registration form.

We hope to see you in Berlin but if you are not able to attend, come see us at the 84th Annual Meeting of the Japanese Pharmacological Society (JPS) on 22nd to 24th, March 2011 in Yokohama Japan, where RPL will be presenting the first ever formal Japanese Caucasian bridging TQT analysis.  In addition, RPL will be appearing at the DIA Euro Meeting (booth 1541), taking place 28-31 March in Geneva, Switzerland.

March promises to be quite an eventful month for RPL and we look forward to the prospect of developing new relationships in the weeks to come. From Japan to Geneva to Berlin, here�s to crossing paths later this month!

Joint Conference of European Human Pharmacology Societies:

Latest news

Upcoming Event

On Helix, Transforming new medicine discovery

13-14 July 2020
Richmond Pharmacology will be showcasing a presentation on Adaptive Early Phase Clinical Trials as part of the ON HELIX digital event.
View event

COVID-19 – External Monitoring Guidelines

July 1, 2020
Richmond Pharmacology is constantly assessing health and safety risks posed by COVID-19 and is regularly reviewing Public Health England guidance.
Read more

First transdermal patch to treat schizophrenia hits market

March 18, 2020
The US Food and Drug Administration (FDA) has officially approved a transdermal patch to treat schizophrenia developed by Hisamitsu Pharmaceutical Co following successful
Read more

Statement: COVID-19

March 23, 2020
Richmond Pharmacology are continuously risk-assessing our activity in relation to the COVID-19 crisis and we are evaluating what activity can continue, what precautions need to be put in place and what needs to be suspended.
Read more